| abstract |
The lipid is of the type (I) and/or (II) where L is a long chain acyl radical, M is a medium chain acyl radical, and S is a short chain acid radical. This lipid can successfully be used for production of a pharmaceutical preparation for treatment of pancreatic insufficiency, primary biliary cirrhosis or cystic fibrosis. |